Epidermal growth factor |
EGF |
100 ng/ml |
– |
R&D Systems, Minneapolis, MN, USA |
Sphingosine-1-phosphate |
S1P |
100 nM |
– |
Sigma-Aldrich, St. Louis, MO, USA |
Endothelin-1 |
ET-1 |
100 nM |
– |
Sigma-Aldrich, St. Louis, MO, USA |
Thrombin |
Thr |
2 U/ml |
– |
GE Healthcare, Chicago, IL, USA |
AG1478 |
– |
250 nM |
EGFR inhibitor |
Selleckchem, Houston, TX, USA |
AG879 |
– |
2 μM |
ErbB2 inhibitor |
Selleckchem, Houston, TX, USA |
Wortmannin |
WT |
100 nM |
PI3K inhibitor |
Enzo, Farmingdale, NY, USA |
Akt inhibitor VIII |
Akt VIII i |
1 μM |
Akt inhibitor VIII |
Sigma-Aldrich, St. Louis, MO, USA |
PD98059 |
– |
10 μM |
Mitogen-activated protein kinase (MEK)/ERK1/2 inhibitor |
Merck Life Science, Milano, Italy |
YM-254890 |
– |
100 nM |
Gαq inhibitor |
Adipogen Life Sciences, San Diego, CA, USA |
Pertussis toxin |
PTX |
10 ng/ml |
Gi inhibitor |
Tocris Bioscience, Bristol, UK |
Batimastat |
– |
20 nM |
Metalloprotease (MMP) inhibitor |
Tocris Bioscience, Bristol, UK |
Ilomastat |
– |
1 μM |
Metalloprotease (MMP) inhibitor |
Tocris Bioscience, Bristol, UK |
W146 |
– |
100 nM |
Selective antagonist of S1PR1 |
Sigma-Aldrich, St. Louis, MO, USA |
JTE-013 |
– |
10 nM |
Selective antagonist of S1PR2 |
Sigma-Aldrich, St. Louis, MO, USA |
TY-52156 |
– |
100 nM |
Selective antagonist of S1PR3 |
Sigma-Aldrich, St. Louis, MO, USA |
CYM-50358 |
– |
1 nM |
Selective antagonist of S1PR4 |
Sigma-Aldrich, St. Louis, MO, USA |
BQ123 |
– |
0.65 μg/ml |
Endothelin A receptor antagonist |
Sigma-Aldrich, St. Louis, MO, USA |
BQ788 |
– |
0.65 μg/ml |
Endothelin B receptor antagonist |
Sigma-Aldrich, St. Louis, MO, USA |
SCH79797 |
– |
10 nM |
Selective antagonist of PAR-1 |
Tocris Bioscience, Bristol, UK |
tcy-NH2 |
– |
10 μM |
Selective antagonist of PAR-4 |
Tocris Bioscience, Bristol, UK |
Monoclonal antibody to PAR1 (ATAP2, sc-13503) |
mAb to PAR1 |
1 mg/ml |
– |
Santa Cruz Biotechnology, Dallas, TX, USA |